Bullfrog AI Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bullfrog AI Holdings, Inc. (Nasdaq: BFRG) on February 27, 2025. The company is incorporated in Nevada and is classified as an emerging growth company. The report primarily addresses a strategic business development rather than periodic financial results.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a notice of a corporate event and does not contain audited or unaudited financial statements for the period.
Material Changes and Events
Under Item 8.01 (Other Events), the company announced the entry into a collaboration agreement with Eleison Pharmaceuticals Inc. on February 27, 2025. The full details of this agreement are contained in the press release attached as Exhibit 99.1, which is incorporated by reference.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future performance, or specific risk factors related to the new collaboration. No unusual items or contingencies were disclosed in the body of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific terms, financial commitments, and scope of the collaboration with Eleison Pharmaceuticals Inc.
- Verify the impact of this partnership on the company's strategic roadmap and potential revenue streams.
- Check subsequent filings for any material agreements or financial implications arising from this collaboration.
- Confirm the current trading status of Common Stock (BFRG) and Tradeable Warrants (BFRGW) on The Nasdaq Capital Market.